Back

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

June 8, 2026

More like this

July 1, 2026

Beyond the Pill: Remepy's Hybrid Drug Shows It Can Remodel Brain Networks

Brief Glance

July 1, 2026

Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa™, Effect on Structural Connectivity in the Brain of Parkinson's Patients Associated with Improved Clinical Outcome

Press Release

May 21, 2026

Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial

Neurology Live